Frier Levitt launches new practice for regenerative medicine

Kimberly Redmond//March 26, 2025//

Stethoscope and gavel

PHOTO: DEPOSIT PHOTOS

Stethoscope and gavel

PHOTO: DEPOSIT PHOTOS

Frier Levitt launches new practice for regenerative medicine

Kimberly Redmond//March 26, 2025//

Listen to this article

Pine Brook-based boutique health care law firm is launching a Regenerative Medicine, Anti-Aging and Wellness multidisciplinary practice group.

Partner Arielle Miliambro – a 2025 NJBIZ Leaders in Law honoree – and senior counsel Martha Rumore lead the newly formed team of health care and life sciences attorneys. The group provides tailored legal services to regenerative health care businesses and industry stakeholders as they navigate the complex regulatory landscape in a rapidly growing sector. 

Defined by Mayo Clinic as medicine “focused on rebuilding health by repairing, replacing or restoring damaged tissues, cells or organs,” the sector is becoming a vital component of medical and surgical practice. Examples of regenerative treatments include bone marrow, hormone replacement, stem cells and platelet-rich plasma therapies.

Spurred by innovations in personalized care, cash-pay services and new treatments, the U.S. regenerative medicine market is projected to reach $49 billion by 2028, according to data from research platform Markets and Markets.

As these services gain popularity, so does the need for businesses and practices to ensure compliance with evolving state and federal regulations.

According to Frier Levitt, the Regenerative Medicine, Anti-Aging and practice group offers clients legal counsel on matters such as:
  • Regulatory compliance at both state and federal levels
  • Formation of management services organizations (MSOs)
  • Corporate transactions and structuring
  • Licensing agreements and governing documents
  • Telemedicine protocols
  • Intellectual property protections
  • U.S. Food and Drug Administration and Board of Pharmacy inspection preparation

 

“As the regenerative medicine industry continues to expand, providers must stay ahead of the shifting regulatory frameworks. Our attorneys are uniquely equipped to guide clients through the legal challenges that arise in this dynamic field, allowing them to focus on delivering innovative treatments while maintaining compliance,” commented firm co-founder Daniel Frier.

Founded in 2000, Frier Levitt boasts a team of 50-plus attorneys. It serves providers, wholesalers, manufacturers, plan sponsors, large physician group practices, hospitals, hospital medical staff, ambulatory surgery centers and laboratories. The firm also offers legal counsel in areas such as corporate transactions, regulatory compliance, intellectual property and litigation.